Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Letrozole-d4 | 1133712-96-5 | 99.23% | C17H7D4N5 | 1 MG
Supplier: Medchemexpress LLC HY14248S1MG
Letrozole-d4 (CGS 20267-d4) is a deuterium-labeled version of Letrozole. Letrozole (CGS 20267) is described as a potent, selective, reversible, and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. It selectively inhibits estrogen biosynthesis and is used in breast cancer research.
- Deuterium labeled compound.
- Potent, selective, reversible, and orally active non-steroidal aromatase inhibitor.
- IC50 of 11.5 nM against aromatase.
- Selectively inhibits estrogen biosynthesis.
- Useful for breast cancer research.
- Can be used as a tracer.
- Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?